Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1	acute myeloid leukemia	Recruiting	Phase 3	2026-08-07		NCT06744504

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Institute of Hematology & Blood Diseases Hospital, China	285

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Blood Diseases Hospital	Tianjin	China	12

Clinical trials